Brugada syndrome is a genetic heart rhythm condition that can cause dangerous fast heartbeats and fainting. Many people with Brugada syndrome have no symptoms for years, but some feel palpitations, lightheadedness, or sudden fainting, often during rest or fever. It is usually recognized in adults, more often in men, and it is lifelong, with risk that can vary over time. The main treatment is an implantable cardioverter defibrillator for those at higher risk, and careful fever control and certain medicines are also used. Sudden cardiac death can occur, but many people with Brugada syndrome live long lives with monitoring and the right care.
How many people live with Brugada syndrome?
A 2018 global review estimated that about 2 to 5 out of every 10,000 people have Brugada syndrome; applied to the 2020 world population (about 7.8 billion), that suggests roughly 1.6 to 3.9 million people worldwide. Using the same rate with the 2020 U.S. population (about 331 million) suggests about 66,000 to 166,000 people in the United States.
Overview
Brugada syndromeSymptoms
Brugada syndrome often causes no symptoms. Possible early symptoms of Brugada syndrome include fainting, pounding heartbeat, or seizure-like episodes—often during rest, sleep, or fever; some have nighttime gasping. In rare cases, the first sign is sudden cardiac arrest.
Outlook and prognosis
Many people with Brugada syndrome live long, active lives, especially when the condition is recognized and monitored. The main risk is dangerous heart rhythms, which can be reduced with tailored care—like avoiding certain drugs, treating fevers promptly, and, for some, an ICD. Prognosis varies by symptoms, ECG pattern, family history, and genetic findings.
Causes and risk factors
Brugada syndrome usually stems from inherited changes in heart‑rhythm genes, often passed in families. Risk rises with male sex, family history, fever, medicines or stimulants, electrolyte imbalance, and Southeast Asian ancestry. Some develop a Brugada-like pattern from drugs or illness.
Genetic influences
Genetics plays a major role in Brugada syndrome; many cases run in families in an autosomal dominant pattern. Variants in sodium channel genes, especially SCN5A, are common but not always found. Genetic testing can guide family screening, risk counseling, and management.
Diagnosis
Doctors diagnose Brugada syndrome by its characteristic ECG pattern, sometimes unmasked with a medication or fever. They review fainting, cardiac arrest, and family history, while ruling out other causes. Genetic diagnosis of Brugada syndrome can support but isn’t required.
Treatment and drugs
Treatment for Brugada syndrome focuses on preventing dangerous heart rhythms and lowering sudden cardiac risk. Care may include an implantable cardioverter-defibrillator (ICD), careful use or avoidance of certain medications, fever management, and sometimes catheter ablation for specific rhythm triggers. Regular follow-ups, family screening, and personalized plans guide daily safety.
Symptoms
Many people with Brugada syndrome feel well most of the time, with no hints of trouble during daily routines. Early features of Brugada syndrome may be silent, though some experience sudden fainting or nighttime gasping when the heart rhythm briefly goes off track. Features vary from person to person and can change over time. Fever, certain medications, or heavy alcohol use can bring out the condition’s typical heart rhythm changes.
Brief loss of consciousness can happen when the heartbeat becomes dangerously fast and the brain gets less blood. It often occurs at rest or during sleep and may follow a fever.
Some feel a racing, pounding, or fluttering heartbeat that comes and goes. This may be paired with lightheadedness or near-fainting and can last seconds to minutes.
Bed partners may notice sudden gasping or snorting breaths during sleep. This can be a sign of a dangerous heart rhythm in Brugada syndrome.
Shaking or jerking movements can occur when fainting cuts blood flow to the brain. These events may look like epilepsy but stem from a heart rhythm problem.
How people usually first notice Brugada syndrome?
Many people first notice Brugada syndrome when a fainting spell happens during rest or sleep, often after a fever or illness, and loved ones may describe gasping or an abnormal nighttime breathing pattern. Sometimes the first signs of Brugada syndrome appear on an electrocardiogram (ECG) done for another reason, showing a characteristic pattern even before symptoms. In families with a known history of sudden cardiac death at a young age, doctors may look more closely and spot how Brugada syndrome is first noticed through that telltale ECG pattern or fainting episodes triggered by fever or certain medicines.
Types of Brugada syndrome
Brugada syndrome has several recognized clinical patterns that help doctors talk about risk and day‑to‑day impact. These variants are defined mostly by the ECG pattern and, less commonly, by which gene is involved. Not everyone will experience every type. Here are the main types to know about, and how symptoms can differ if you’re looking up types of Brugada syndrome.
Type 1 ECG pattern
This pattern shows the classic “coved” elevation in the right chest leads on an ECG. People may faint, feel palpitations, or have no symptoms at all. It’s linked to a higher risk of dangerous heart rhythms.
Type 2 ECG pattern
The ECG shows a “saddleback” shape, which is less specific for Brugada syndrome. Many living with this pattern have few or no symptoms. Further testing is often needed to clarify risk.
Type 3 ECG pattern
The tracing can look like type 1 or 2 but is milder and non‑specific. Symptoms don’t always look the same for everyone. Doctors usually rely on additional tests or changes over time to decide if this truly fits Brugada syndrome.
SCN5A‑related variant
Changes in the SCN5A gene can affect the heart’s sodium channel and the timing of each heartbeat. Some people notice more fainting or nighttime symptoms, while others remain symptom‑free. Risk and severity can vary even within the same family.
Non‑SCN5A variants
Less commonly, variants in other genes tied to heart rhythm may be found. These are rarer and their impact can be harder to predict. People may need tailored evaluation based on family history and ECG findings.
Can I slow down the onset of symptoms?
There isn’t a proven way to delay when Brugada syndrome begins, because it’s present from birth, but you can lower the chance of symptoms and dangerous heart rhythms by avoiding known triggers. Treat fever quickly, avoid medicines that can trigger Brugada (ask your doctor or check a trusted list), avoid heavy drinking and any stimulant or street drugs, and keep up fluids and salts, especially if you’re sick with vomiting or diarrhea. For people at higher risk, doctors may recommend a small implanted defibrillator to stop a dangerous rhythm and may offer heart checks to close relatives; these steps can reduce risk but can’t guarantee prevention, and working with a heart‑rhythm specialist can help you make a safe plan.
What genetics can tell you about symptoms
Genetics can help explain why symptoms of Brugada syndrome vary so much—from no symptoms at all to fainting, dangerous heart rhythms, or sudden cardiac arrest, often during sleep. Changes in certain heart rhythm genes, especially SCN5A, can raise the chance of abnormal electrical signals, which may influence how early problems start, how often they happen, and how severe they are, though many people with a gene change never develop symptoms. Family testing can clarify who may be at higher risk and guide monitoring, but genes don’t predict everything; fever, certain medicines, and heavy alcohol use can also trigger symptoms.
Causes and risk factors
Brugada syndrome often stems from an inherited change in a heart rhythm gene.
The change can run in families or appear for the first time.
Genes set the stage, but environment and lifestyle often decide how the story unfolds.
Fever or certain medicines can unmask the rhythm problem and raise risk.
Key risk factors for Brugada syndrome are being male, Southeast Asian ancestry, family history of sudden cardiac death, and heavy alcohol use.
What are the most common causes or risk factors?
Brugada syndrome is most often linked to an inherited change in a gene that helps control the heart’s electrical signals (often a gene called SCN5A), though in some people no gene change is found. Having a close relative with Brugada syndrome or with sudden unexplained death raises risk. Risk is also higher in men and in people of Southeast Asian ancestry, and episodes can be triggered or made worse by fever, certain medicines (for heart rhythm, mood, or anesthesia), recreational drugs like cocaine, heavy alcohol use, or low potassium and other electrolyte problems.
Environmental and biological risk factors
Environmental and biological factors can influence when Brugada syndrome shows up on an ECG or when symptoms arise. Doctors often group risks into internal (biological) and external (environmental). These factors can shape early symptoms of Brugada syndrome and help explain why risk varies from day to day. Here are the key ones to know.
Men are more likely to show the ECG pattern and experience dangerous rhythms in Brugada syndrome. Sex hormones appear to influence how heart cells handle electricity. This raises risk for males across many regions.
People with Southeast or East Asian ancestry have higher reported rates of this condition. Clusters have been described in Thailand, Japan, and the Philippines. Biological differences in cardiac signaling may contribute.
Many diagnoses and events occur in adulthood, often between ages 30 and 50. Children and older adults can be affected, but less often.
High fever can unmask the Brugada ECG pattern and trigger abnormal heart rhythms. During a viral illness with 39°C (102°F) fever, problems can emerge even in someone who felt well before. Overheating from any cause shifts electrical currents in Brugada syndrome.
Genetic risk factors
Genetics play a major role in Brugada syndrome, but the picture is complex. Carrying a genetic change doesn’t guarantee the condition will appear. Most known changes affect the heart’s sodium channel gene, yet many people diagnosed have no identifiable variant on current tests. Genetic findings can clarify personal and family risk and guide who else in a family might be offered checks.
SCN5A variants: Changes in this sodium channel gene are the most established genetic cause of the condition. They are found in roughly one in five to one in three diagnosed people and can reduce the heart’s electrical signal. The same SCN5A change can look different across relatives.
Autosomal dominant inheritance: One altered copy can be enough to raise risk, so each child has a 50% chance of inheriting it. Not everyone who inherits the change will show ECG (electrocardiogram) features or symptoms, a concept called reduced penetrance. Families may see a mix of normal and Brugada-type tracings.
De novo variants: Sometimes a genetic change arises for the first time in someone with Brugada syndrome. In this situation, parents may test negative even though the variant is truly disease-related. Confirming this can refine recurrence risks for future children.
Other genes under study: Variants in additional ion-channel or related genes have been reported in a small proportion of cases. Evidence for most of these genes is limited, so results may be classified as uncertain today. This is why genetic testing for Brugada syndrome often starts with SCN5A and may use broader panels if needed.
Genetic modifiers: Common DNA differences across the genome can influence ECG patterns and arrhythmia risk. These do not cause the condition by themselves but may nudge risk up or down. Such findings are not yet part of routine clinical risk scores.
Ancestry background: Brugada syndrome is diagnosed more often in people with Southeast Asian or East Asian ancestry. Genetic background likely contributes to this pattern, although the exact variants behind it are still being mapped. This knowledge can guide family awareness and screening.
Sodium channel spectrum: Some SCN5A changes can also appear in families with conduction disease or a form of long QT. This overlap reflects how one gene can shift heart rhythms in different ways. A clinical genetics team can help interpret the pattern seen in your family.
Lifestyle risk factors
Brugada Syndrome is an inherited heart rhythm condition; lifestyle habits do not cause it, but they can influence symptom triggers and complication risk. Day-to-day choices can raise or lower the chance of dangerous heart rhythms, especially during illness or physiologic stress. Below is a practical look at how lifestyle affects Brugada Syndrome and the key lifestyle risk factors for Brugada Syndrome.
Fever can unmask Brugada ECG changes and trigger dangerous arrhythmias. Aggressive fever treatment with antipyretics and fluids during infections can lower this risk.
Heavy or binge drinking increases arrhythmia risk in Brugada Syndrome by affecting heart electrical channels and autonomic tone. Limiting alcohol and avoiding binges can reduce nighttime and post-drinking triggers.
Cocaine, amphetamines, and similar stimulants can block cardiac sodium channels and precipitate life‑threatening rhythms in Brugada Syndrome. Absolute avoidance of these substances is recommended to reduce trigger events.
Dehydration or low potassium/magnesium from sweating, vomiting, diarrhea, or extreme diets can destabilize heart rhythms in Brugada Syndrome. Steady hydration and balanced nutrition that maintains electrolytes can help prevent arrhythmia triggers.
Risk prevention
Brugada syndrome can’t be prevented entirely, but you can lower the chance of dangerous heart rhythms and sudden events. Day to day, that means avoiding known triggers, keeping infections and fevers under control, and staying connected with a heart specialist who knows this condition well. Knowing your risks can guide which preventive steps matter most. If you ever develop fainting, seizure-like episodes, or gasping during sleep, treat this as urgent and seek care right away.
Treat fevers promptly with acetaminophen/paracetamol and fluids because fever can trigger abnormal heart rhythms in Brugada syndrome. Seek urgent care if a fever is high, persistent, or comes with fainting or chest discomfort.
Avoid medicines that raise risk in Brugada syndrome, including certain heart drugs, some antidepressants/antipsychotics, and some anesthetics or antibiotics. Always ask your doctor or pharmacist before starting new prescriptions, over‑the‑counter drugs, or supplements, and carry a wallet list of medicines to avoid.
Limit alcohol and avoid binge drinking, which can trigger arrhythmias or worsen dehydration. Do not use cocaine, amphetamines, or other stimulants, as they can be dangerous for people with Brugada syndrome.
Stay well hydrated, especially during heat, exercise, or illness, to help keep salts like potassium in a safe range. If you have vomiting, diarrhea, or use water pills, talk with your clinician about checking electrolytes.
Can you prevent Brugada syndrome?
You can’t prevent Brugada syndrome itself, because it’s usually inherited, but you can lower the chance of dangerous heart rhythms. Treat fevers promptly, avoid medicines that can trigger the condition (check with your doctor or pharmacist), limit heavy alcohol use, avoid recreational drugs like cocaine, and keep your body salts in a healthy range by staying well hydrated and following your care plan. If it runs in your family, relatives can ask about screening and genetic counseling, which doesn’t prevent it but can find it early and guide steps to reduce risk.
Transmission
Brugada syndrome is not contagious; it doesn’t spread through touch, air, food, or blood. Most often, it runs in families in an autosomal dominant pattern—if a parent carries the gene change linked to Brugada syndrome, each child has a 1 in 2 (50%) chance of inheriting it. This genetic transmission of Brugada syndrome can be unpredictable: some who inherit the change never develop symptoms or an abnormal ECG, yet they can still pass it on. It can also appear for the first time in a family due to a new (de novo) gene change, and in some people no specific gene change is found even though the ECG pattern fits. If you’re wondering how Brugada syndrome is inherited in your family, genetic counseling and testing of close relatives can help clarify individual risk.
When to test your genes
Consider genetic testing if you or a first‑degree relative has a confirmed Brugada pattern on ECG, unexplained fainting, nighttime agonal breathing, or a history of sudden cardiac arrest—especially in your 20s–40s. Test earlier for family planning, sports clearance, or anesthesia planning. Re‑test if your family’s variant is newly identified.
Diagnosis
You might notice small changes in daily routines, like fainting during a fever or waking at night with a racing heartbeat—clues that prompt heart testing for Brugada syndrome. Doctors usually begin with a careful review of symptoms, a resting heart tracing (ECG), and questions about any fainting, seizures without a clear cause, or a family history of sudden cardiac death. Because the heart can look normal between events, repeat or specialized ECGs are often needed to confirm the pattern. Some tests focus on ruling out look-alike causes so the diagnosis is as accurate as possible.
Clinicians look for a characteristic pattern in the right chest leads, especially a coved ST elevation known as a type 1 pattern. This ECG finding is central to the diagnosis of Brugada syndrome.
Moving the chest electrodes one or two spaces higher can bring out the typical pattern. Repeat ECGs at different times or during a fever may also reveal changes not seen on a single test.
In a monitored setting, a medicine that briefly blocks certain heart channels (such as ajmaline, flecainide, or procainamide) may unmask the type 1 pattern. This helps confirm Brugada syndrome when the resting ECG is nondiagnostic.
Providers check for conditions that can copy the ECG look, such as fever, low potassium, certain medications, or a recent heart attack. Treating or removing these triggers first helps avoid a mistaken diagnosis.
How is Brugada syndrome diagnosed?
Doctors diagnose Brugada syndrome mainly with a heart tracing called an electrocardiogram (ECG) that shows a characteristic pattern; if it doesn’t appear at first, they may repeat the ECG, move the chest stickers slightly higher, record during a fever, or give a carefully supervised medicine to bring out the pattern. They also consider symptoms like fainting or sudden nighttime gasping, any history of dangerous heart rhythms, and family history of sudden death, and they rule out other causes with an exam and tests such as an ultrasound of the heart (echocardiogram). Genetic testing can sometimes find a related gene change and is most useful for checking relatives, but it isn’t required for diagnosis and often is negative even when the ECG pattern is clear.
Stages of Brugada syndrome
Brugada Syndrome does not have defined progression stages. It doesn’t usually worsen step by step; some people never have symptoms, while others may have sudden episodes triggered by fever or certain medicines, and the ECG pattern can appear and disappear over time. Diagnosis is based on a characteristic heart tracing on an electrocardiogram (ECG), your history (including early symptoms of Brugada syndrome like fainting or nighttime irregular heartbeats), and family background; Different tests may be suggested to help confirm the pattern and assess risk. Ongoing care often includes repeat ECGs, fever precautions, and, when appropriate, genetic testing and specialist follow-up to monitor risk over time.
Outlook and prognosis
Most people with Brugada syndrome remain asymptomatic and can live a normal lifespan, but the condition carries a lifelong risk of ventricular arrhythmias that can cause syncope or sudden cardiac death, particularly in young to middle-aged adults and often during rest or sleep. Prognosis depends on risk profile: those with prior cardiac arrest, documented sustained ventricular arrhythmias, or spontaneous type 1 ECG pattern and recurrent syncope have the highest event rates and benefit most from an implantable cardioverter-defibrillator (ICD). Individuals identified through family screening with no symptoms and only drug-induced ECG changes generally have a low annual event rate, though ongoing follow-up is important. Triggers such as fever, certain medications, heavy alcohol intake, and large meals can worsen arrhythmic risk, so strict avoidance and prompt fever treatment improve outlook. With contemporary risk stratification, lifestyle modification, and use of ICDs or quinidine in select cases, overall mortality is substantially reduced, and many patients never experience malignant arrhythmias. Importantly, the outlook for Brugada Syndrome continues to improve as risk prediction tools and genotype–phenotype insights evolve.
Long-term effects
Brugada syndrome can shape the heart’s electrical behavior over many years, sometimes without any outward signs. Long-term effects vary widely, from a quiet course with no episodes to dangerous fast rhythms that can cause collapse. Some live for decades without events, while others have episodes that cluster at night, during rest, or with fever. Risk can ebb and flow across life stages and tends to be higher in males.
Fast, unstable heart rhythms can occur, including ventricular tachycardia or fibrillation. These events can lead to sudden cardiac arrest, often without much warning. Risk can persist lifelong even when the heart’s structure looks normal.
Early symptoms of Brugada syndrome like fainting or brief nighttime gasping can precede serious rhythm problems. These spells may be separated by long quiet stretches. They often happen during sleep or shortly after waking.
There is an ongoing risk of sudden death in people who have high-risk features or prior serious rhythm events. Episodes tend to occur at night or at rest. The overall risk level depends on individual factors seen on testing and history.
Fever, certain medicines, or heavy alcohol intake can unmask the ECG pattern or provoke dangerous rhythms. This sensitivity can remain present for life. Some people notice that episodes cluster around infections or hot environments.
How is it to live with Brugada syndrome?
Living with Brugada syndrome often means feeling well day to day while carrying an invisible risk that asks for steady attention rather than constant worry. Many people build safe routines—avoiding overheating, heavy alcohol use, and certain medications; treating fevers quickly; and keeping follow-up visits—so they can work, exercise reasonably, travel, and plan families with confidence. Loved ones may share the emotional load, learning how to recognize warning signs like fainting and when to call for help, and some families choose screening so relatives can understand their own risk. For many, having an implanted defibrillator or a clear emergency plan turns uncertainty into preparedness, allowing life to feel full and forward-looking.
Treatment and drugs
Brugada syndrome treatment focuses on preventing dangerous heart rhythms and lowering the risk of sudden cardiac arrest. The mainstay for people at high risk—such as those who’ve fainted due to a heart rhythm problem or survived a cardiac arrest—is an implantable cardioverter-defibrillator (ICD), a small device placed under the skin that can quickly correct life‑threatening rhythms. Some may also benefit from a catheter ablation procedure, which targets the heart tissue that triggers abnormal electrical signals, especially if recurrent abnormal rhythms or frequent ICD shocks occur. Medicines are limited, but in emergencies doctors may use drugs like isoproterenol in the hospital; at home, avoiding fever, certain medications that can unmask Brugada syndrome, heavy alcohol intake, and dehydration is important, and your care team will provide a medication safety list. Not every treatment works the same way for every person, so regular follow‑up with a heart rhythm specialist helps tailor your plan and adjust it over time.
Can you cure Brugada syndrome?
There’s no cure for Brugada syndrome, but treatment can greatly lower the risk of dangerous heart rhythms and sudden cardiac arrest. Depending on your risk, care may include an implantable cardioverter-defibrillator (ICD)—a small device that can correct a life‑threatening rhythm—along with careful fever control and avoiding medicines that can trigger problems. Regular checkups with a heart rhythm specialist help keep your plan up to date.
Non-drug treatment
Non-drug care for Brugada syndrome focuses on lowering the chance of dangerous heart rhythms in daily life and during illness. Alongside medicines, non-drug therapies can reduce triggers and add layers of protection. Plans are tailored to your personal risk—whether you’ve had fainting, abnormal ECGs, or early symptoms of Brugada syndrome. Care usually blends practical safety steps with procedures used when risk is higher.
A small device under the skin that can stop life-threatening rhythms with a quick shock. It’s recommended for those at higher risk or after cardiac arrest or fainting with high-risk ECG features. It requires periodic checks but is the most effective safety net.
A specialist threads thin wires into the heart to neutralize tiny areas that trigger dangerous rhythms. It’s used for recurrent fainting, frequent ICD shocks, or electrical storm despite other measures. This procedure is offered in experienced centers after careful evaluation.
Fever can trigger abnormal rhythms in Brugada syndrome. Treat fevers early with acetaminophen/paracetamol and fluids, and seek urgent care if symptoms worsen. Keep a home thermometer and an action plan for illness.
Some prescription and recreational drugs can unmask or worsen the ECG pattern and trigger arrhythmias. Always check a reliable Brugada drug-avoid list and ask a clinician before new medicines or anesthesia. Avoid cocaine and similar stimulants.
Your genes may have an impact on how drugs work for you
Your genes can influence how your body handles certain heart medicines and common drugs, which matters for people with Brugada syndrome because some medicines can worsen the heart’s electrical signals and raise the risk of dangerous rhythms. Small genetic differences may change how quickly your liver breaks down a drug or how strongly your heart’s channels react to it, so a dose that’s fine for one person could be risky for another. Pharmacogenomic testing and a careful medication review with your cardiologist can help avoid problem drugs, choose safer options, and set the right dose.
Pharmacological treatments
Medicines for Brugada syndrome focus on preventing dangerous heart rhythm spikes, especially during fevers or sudden clusters of fainting spells. They don’t fix the underlying electrical pattern or early symptoms of Brugada syndrome, but they can steady the heart and lower the risk of cardiac arrest. Not everyone responds to the same medication in the same way. Choices depend on whether treatment is urgent in the hospital or for longer-term protection.
This intravenous medicine is used in the hospital to quickly calm dangerous rhythm clusters (electrical storms) in Brugada syndrome. It works by gently speeding the heart and stabilizing its signaling, with continuous heart monitoring.
Oral quinidine or hydroquinidine may be used long-term to reduce life‑threatening ventricular rhythms or cut down on implantable defibrillator shocks. Doctors check ECGs and electrolytes to watch the QT interval and adjust the dose if side effects like stomach upset occur.
Acetaminophen (paracetamol) or ibuprofen at the first sign of fever can lower a key trigger for arrhythmias in Brugada syndrome. Treat fevers promptly, stay hydrated, and seek urgent care if dizziness, fainting, or palpitations occur with fever.
When quinidine isn’t available or tolerated, cilostazol may be considered by specialists to raise heart rate slightly and reduce arrhythmia risk. It’s off‑label, requires close follow‑up, and isn’t suitable for people with significant heart failure.
Genetic influences
In many families, Brugada syndrome can run across generations because of a single gene change that affects the heart’s electrical signaling. The most commonly affected gene controls a key sodium channel, a kind of gate that helps each heartbeat fire on time. Inheritance is usually “dominant,” meaning if you carry the change, each child has a 1 in 2 (50%) chance to inherit it. Having a gene change doesn’t always mean you will develop the condition. Some people with the gene never have symptoms or an abnormal ECG, while others may only show changes during a fever or with certain medicines. Genetic testing for Brugada syndrome can find a cause in roughly a quarter to a third of families, so a negative result doesn’t rule it out but can still guide screening of relatives.
Is Brugada syndrome genetic?
Genetics plays a major role in Brugada syndrome; many cases run in families in an autosomal dominant pattern. Variants in sodium channel genes, especially SCN5A, are common but not always found. Genetic testing can guide family screening, risk counseling, and management.
Having a genetic risk is not necessarily a diagnosis
Genetic differences are a normal part of being human and are widespread in the population. Most of these differences do not directly affect health and simply reflect natural human variation. For many genes, having a change linked to a condition suggests a possible connection rather than a certain diagnosis, especially when multiple genes and environmental factors are involved. That said, in some situations, a single well-studied change in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For Brugada Syndrome, inherited changes in the heart’s sodium‑channel genes—most often SCN5A—can shape how certain medicines act on your heart’s wiring. Drugs that block sodium channels, including some heart rhythm medicines, certain antidepressants or antipsychotics, and a few anesthetics, can unmask or worsen the Brugada ECG pattern and raise the chance of dangerous rhythms, so clinicians often build a personalized list of medications to avoid with Brugada syndrome. Quinidine, a long‑used rhythm medicine, may help reduce abnormal beats in some people because it can offset the underlying electrical imbalance, but genetic results don’t yet predict who will benefit most or what dose to use.
Implantable defibrillators remain the main safety net for those at higher risk, with medicines used carefully around that—especially during fevers, illness, or surgery. Not every difference in response is genetic, but knowing your specific variant can alert your team to drug sensitivities and guide safer choices for anesthesia and everyday prescriptions. Today, pharmacogenetic testing in Brugada mainly supports confirming the diagnosis and family screening; it informs which drug classes to avoid, rather than fine‑tuning how quickly your body breaks down a drug.
Interactions with other conditions
Fevers from infections can unmask or worsen the risk of dangerous heart rhythms in Brugada Syndrome, so even a bad cold or flu may matter; for some, early symptoms of Brugada syndrome first appear during a feverish illness. Other rhythm problems, especially atrial fibrillation, are more common in people with Brugada Syndrome and can complicate monitoring and treatment decisions. Shared genetic variants may explain why certain conditions cluster together. Breathing problems during sleep, such as obstructive sleep apnea, may add nighttime strain on the heart’s electrical system and raise the chance of arrhythmias. Inflammation of the heart muscle (myocarditis) or a heart attack can create Brugada-like ECG changes and may heighten risk until the underlying illness improves. Stomach bugs that cause vomiting or diarrhea can disrupt electrolytes, which in people with Brugada Syndrome might trigger fainting or serious rhythm issues. Because these links vary widely, it’s important to manage fevers promptly, review any new diagnoses with your cardiologist, and seek coordinated care during other illnesses.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Brugada syndrome?
Symptoms like fainting, a pounding or racing heartbeat, or sudden collapse can also come from common fainting spells, a sudden drop in blood pressure when standing, panic attacks, or seizures that can look like passing out. Heart problems that may be mistaken for Brugada include a heart attack or blocked heart arteries, a thickened heart muscle, a disease of the right heart muscle that causes dangerous rhythms, and other inherited rhythm disorders such as long QT syndrome.
History
Throughout history, people have described sudden, unexplained nighttime deaths, often in otherwise healthy young adults. Families and communities once noticed patterns—an uncle who died in his sleep, a cousin who fainted with a fever—without a clear cause. These stories echoed across regions in Southeast Asia and elsewhere, long before doctors understood the shared thread. Today we recognize many of these events as tied to Brugada syndrome, a heart rhythm condition that can trigger dangerous arrhythmias, especially during rest or illness.
First described in the medical literature as a distinct electrocardiogram (ECG) pattern in 1992 by Pedro and Josep Brugada, the syndrome linked a characteristic “coved” ST elevation on ECG with a risk for sudden cardiac death. Early reports connected fainting, seizures misread as epilepsy, and collapse during sleep with this ECG signature. Over time, descriptions became clearer: some people with Brugada syndrome have the ECG changes all the time, while others show them only during fever, certain medications, or after a specific drug given in a monitored setting to unmask the pattern.
From early theories to modern research, the story of Brugada syndrome has moved from observation to mechanism. In the late 1990s, scientists identified changes in a gene that affects a sodium channel in the heart (commonly SCN5A) in a subset of families. This helped explain why the heart’s electrical signals can misfire, like a dimmer switch set too low for stable conduction. Advances in genetics have since shown that Brugada syndrome is variable: not all people have an identifiable gene change, and the same family can have different levels of risk.
In recent decades, awareness has grown, especially regarding triggers and regional patterns. Fever emerged as an important risk factor for arrhythmias in Brugada syndrome, guiding everyday advice to treat high temperatures promptly. Researchers also noted that the condition appears more often in people assigned male at birth and can be more common in certain populations, helping tailor screening and prevention. Doctors refined ECG criteria, developed drug-challenge tests, and studied which features best predict risk—such as a history of fainting with documented arrhythmia—so treatment could focus on those most likely to benefit.
These historical steps shaped today’s care. Implantable cardioverter-defibrillators (ICDs) became the main protection for those at highest risk, while careful medication review, fever management, and family screening form the backbone of prevention for many others. Looking back helps explain why early symptoms of Brugada syndrome were easy to miss and sometimes mislabeled, and it highlights how combining community experience, ECG recognition, and genetics transformed a set of alarming, unexplained events into a condition we can identify, monitor, and, in many cases, effectively manage.